Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-020771

Chairman and CEO bought 4,900 shares at $1.48 ($7,252)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-03-19 Purchase +4,900 $1.48 $7,252 10,498,843 D
Open-market purchases · 4,900 sh · avg $1.48 · $7,252
Loading xslF345X03/doc4.xml…